Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.77B
-
Number of holders
-
3738
-
Total 13F shares, excl. options
-
1.29B
-
Shares change
-
+26.4M
-
Total reported value, excl. options
-
$239B
-
Value change
-
+$4.86B
-
Put/Call ratio
-
0.62
-
Number of buys
-
1820
-
Number of sells
-
-1624
-
Price
-
$185.62
Significant Holders of AbbVie Inc. - Common Stock (ABBV) as of Q2 2025
4,018 filings reported holding ABBV - AbbVie Inc. - Common Stock as of Q2 2025.
AbbVie Inc. - Common Stock (ABBV) has 3,738 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.29B shares
of 1.77B outstanding shares and own 72.75% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (177M shares), BlackRock, Inc. (147M shares), STATE STREET CORP (80M shares), JPMORGAN CHASE & CO (57.2M shares), MORGAN STANLEY (41.7M shares), GEODE CAPITAL MANAGEMENT, LLC (39.2M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (26.8M shares), Capital Research Global Investors (25.3M shares), BANK OF AMERICA CORP /DE/ (25.1M shares), and NORGES BANK (23.1M shares).
This table shows the top 3738 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.